Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Engelsman

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Medical Journal|June 28, 1975
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. studyJ C Heuson, E Engelsman, J Blonk-Van Der Wijst, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)E Engelsman, J C Klijn, R D Rubens, et al.
British Medical Journal|June 28, 1975
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. studyE Engelsman, J C Heuson, J Blonk Van Der Wijst, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)R D Rubens, H Bartelink, E Engelsman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferencesM A Nooij, J C J M de Haes, L V A M Beex, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Medical Journal|June 28, 1975
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. studyJ C Heuson, E Engelsman, J Blonk-Van Der Wijst, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)E Engelsman, J C Klijn, R D Rubens, et al.
British Medical Journal|June 28, 1975
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. studyE Engelsman, J C Heuson, J Blonk Van Der Wijst, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)R D Rubens, H Bartelink, E Engelsman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferencesM A Nooij, J C J M de Haes, L V A M Beex, et al.
Pageof 4